{"id":38034,"date":"2026-03-09T09:30:00","date_gmt":"2026-03-09T08:30:00","guid":{"rendered":"https:\/\/ggba.swiss\/?p=38034"},"modified":"2026-03-09T09:05:31","modified_gmt":"2026-03-09T08:05:31","slug":"alithea-genomics-leve-chf-69-millions-pour-industrialiser-le-sequencage-arn","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/alithea-genomics-leve-chf-69-millions-pour-industrialiser-le-sequencage-arn\/","title":{"rendered":"Alithea Genomics l\u00e8ve CHF 6,9 millions pour industrialiser le s\u00e9quen\u00e7age ARN"},"content":{"rendered":"\n<p><a href=\"https:\/\/alithea-genomics.com\">Alithea Genomics<\/a> a finalis\u00e9 une extension suppl\u00e9mentaire de CHF 3 millions (USD 3,9 millions) de son tour de financement seed, portant le total lev\u00e9 \u00e0 CHF 6,9 millions (USD 8,9 millions). Le tour a \u00e9t\u00e9 men\u00e9 par Genku Ventures, avec la participation de Novalis Biotech, de la Z\u00fcrcher Kantonalbank et de plusieurs investisseurs priv\u00e9s.<\/p>\n\n\n\n<p>Les fonds serviront principalement \u00e0 financer la commercialisation des nouveaux kits MERCURIUS DRUG-seq en format 1536 puits, qui portent la pr\u00e9paration de librairies de s\u00e9quen\u00e7age ARN \u00e0 1&rsquo;536 \u00e9chantillons, rendant accessibles les applications de criblage primaire de m\u00e9dicaments et de toxicologie exploratoire \u00e0 un co\u00fbt et un d\u00e9bit jusqu&rsquo;ici inatteignables. Les fonds soutiendront \u00e9galement le d\u00e9veloppement de nouvelles technologies et la constitution d&rsquo;actifs de donn\u00e9es transcriptomiques propri\u00e9taires pour alimenter les initiatives d&rsquo;intelligence artificielle et d&rsquo;apprentissage automatique dans la d\u00e9couverte de m\u00e9dicaments.<\/p>\n\n\n\n<p>Fond\u00e9e en 2020 \u00e0 l&rsquo;<a href=\"https:\/\/www.epfl.ch\">EPFL<\/a> \u00e0 Lausanne, Alithea Genomics d\u00e9veloppe des solutions de pr\u00e9paration de librairies massivement multiplex\u00e9es pour le s\u00e9quen\u00e7age ARN, notamment BRB-seq et DRUG-seq. Ces plateformes permettent la pr\u00e9paration de centaines \u00e0 des milliers d&rsquo;\u00e9chantillons ARN dans un seul tube, r\u00e9duisant consid\u00e9rablement le co\u00fbt, le temps et les ressources associ\u00e9s aux flux de travail de s\u00e9quen\u00e7age traditionnels.<\/p>\n\n\n\n<p>Parall\u00e8lement \u00e0 ce financement, Frederik Decouttere passe du poste de Pr\u00e9sident du conseil d&rsquo;administration \u00e0 celui de CEO, tandis que le co-fondateur Riccardo Dainese quitte la fonction de CEO pour celle de Chief Commercial Officer, afin de se concentrer sur le d\u00e9veloppement commercial. Kaspar Binz assume quant \u00e0 lui la pr\u00e9sidence du conseil d&rsquo;administration.<\/p>\n\n\n\n<p>Cette \u00e9tape fait suite \u00e0 l&rsquo;<a href=\"https:\/\/ggba.swiss\/fr\/alithea-genomics-franchit-une-nouvelle-etape-de-croissance-avec-un-financement-de-chf-28-millions\/\">extension seed de CHF 2,8 millions finalis\u00e9e en 2024<\/a> et marque la prochaine phase de croissance d&rsquo;Alithea, alors que la soci\u00e9t\u00e9 cible l&rsquo;adoption \u00e0 l&rsquo;\u00e9chelle industrielle de ses plateformes de s\u00e9quen\u00e7age ARN dans la recherche pharmaceutique et au-del\u00e0.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alithea Genomics a finalis\u00e9 son tour de financement seed avec CHF 3 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,9 millions, afin d&rsquo;acc\u00e9l\u00e9rer la commercialisation de ses plateformes de s\u00e9quen\u00e7age ARN \u00e0 grande \u00e9chelle pour le criblage de m\u00e9dicaments et la toxicologie.<\/p>\n","protected":false},"author":6,"featured_media":38031,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1210,1148,1188,1141,1143],"class_list":["post-38034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-diagnostic-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-personalized-medicine-fr-2","tag-vaccines-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alithea Genomics l\u00e8ve CHF 6,9 millions | GGBa<\/title>\n<meta name=\"description\" content=\"Alithea Genomics a finalis\u00e9 son tour de financement seed avec CHF 3 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,9 millions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alithea Genomics l\u00e8ve CHF 6,9 millions | GGBa\" \/>\n<meta property=\"og:description\" content=\"Alithea Genomics a finalis\u00e9 son tour de financement seed avec CHF 3 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,9 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-09T08:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Alithea Genomics l\u00e8ve CHF 6,9 millions pour industrialiser le s\u00e9quen\u00e7age ARN\",\"datePublished\":\"2026-03-09T08:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/\"},\"wordCount\":330,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg\",\"keywords\":[\"Biotech\",\"Diagnostic\",\"Financing\",\"Healthcare\",\"Personalized Medicine\",\"Vaccines\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/\",\"url\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/\",\"name\":\"Alithea Genomics l\u00e8ve CHF 6,9 millions | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg\",\"datePublished\":\"2026-03-09T08:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Alithea Genomics a finalis\u00e9 son tour de financement seed avec CHF 3 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,9 millions.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Alithea Genomics s'est distingu\u00e9e dans le secteur des sciences de la vie gr\u00e2ce \u00e0 ses solutions de s\u00e9quen\u00e7age ARN \u00e0 grande \u00e9chelle. | \u00a9 Alithea Genomics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alithea Genomics l\u00e8ve CHF 6,9 millions pour industrialiser le s\u00e9quen\u00e7age ARN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alithea Genomics l\u00e8ve CHF 6,9 millions | GGBa","description":"Alithea Genomics a finalis\u00e9 son tour de financement seed avec CHF 3 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,9 millions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/","og_locale":"fr_FR","og_type":"article","og_title":"Alithea Genomics l\u00e8ve CHF 6,9 millions | GGBa","og_description":"Alithea Genomics a finalis\u00e9 son tour de financement seed avec CHF 3 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,9 millions.","og_url":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-03-09T08:30:00+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Alithea Genomics l\u00e8ve CHF 6,9 millions pour industrialiser le s\u00e9quen\u00e7age ARN","datePublished":"2026-03-09T08:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/"},"wordCount":330,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg","keywords":["Biotech","Diagnostic","Financing","Healthcare","Personalized Medicine","Vaccines"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/","url":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/","name":"Alithea Genomics l\u00e8ve CHF 6,9 millions | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg","datePublished":"2026-03-09T08:30:00+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Alithea Genomics a finalis\u00e9 son tour de financement seed avec CHF 3 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,9 millions.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Alithea-Genomics-022026-1180x811-1.jpeg","width":1180,"height":811,"caption":"Alithea Genomics s'est distingu\u00e9e dans le secteur des sciences de la vie gr\u00e2ce \u00e0 ses solutions de s\u00e9quen\u00e7age ARN \u00e0 grande \u00e9chelle. | \u00a9 Alithea Genomics"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/alithea-genomics-raises-chf-6-9-million-to-industrialize-rna-sequencing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Alithea Genomics l\u00e8ve CHF 6,9 millions pour industrialiser le s\u00e9quen\u00e7age ARN"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=38034"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38034\/revisions"}],"predecessor-version":[{"id":38036,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38034\/revisions\/38036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/38031"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=38034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=38034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=38034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}